Summary
Updated Aug 31, 2026
Christopher Ryan Sullivan is Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX). 9 SEC Form 4 filings on record, most recently on 19 August 2026. Most recent open-market trade: sold $622K of AVTX on 19 August 2026. Lifetime open-market sales: $3.34M.
Recent Transactions
20Every recent SEC Form 4 transaction Christopher Ryan Sullivan has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Christopher Ryan Sullivan go back to 2026: 9 primary Form 4 filings, an average of 9.0 per year. 25 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Ryan Sullivan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Mittie Doyle - $2.96M of AVTX open-market activity in the last 12 months
- Paul Varki - $1.51M of AVTX open-market activity in the last 12 months
- Jonathan Goldman - $163K of AVTX open-market activity in the last 12 months
- Mitchell Chan - $72K of AVTX open-market activity in the last 12 months
- Jennifer Riley - $52K of AVTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Christopher Ryan Sullivan?
Christopher Ryan Sullivan is a corporate insider, tracked as Chief Financial Officer of Avalo Therapeutics, Inc. (AVTX). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Christopher Ryan Sullivan submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Christopher Ryan Sullivan been buying or selling stock?
Recorded transactions: 0 open-market purchases and 15 open-market sales ($3.34M) across all tracked filings.
Where can I see all of Christopher Ryan Sullivan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Christopher Ryan Sullivan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial